Complete INI-1 (SMARCB1) loss has been implicated in both pediatric and adult mesenchymal tumors, with pediatric malignant rhabdoid tumors (MRTs) and epithelioid sarcomas serving as prototypical examples (19). Here, SMARCB1 is linked to rhabdoid tumor.